Award Sub-Category: Medical Treatment

MIS (Minimally Invasive Surgery) Bunion correction has been clinically proven to achieve the same or better corrective results as traditional bunion surgery, but with major advantages, including a faster recovery, less pain, and less swelling. The AMIB assists surgeons in adopting MIS bunion correction by eliminating several challenges.

Cell reprogramming platform technology is an innovative cell therapy technology that converts cells into therapeutic cells within 15 days as a direct cell cross-differentiation (Cella X) technology based on low molecular weight compounds (drug cocktail composed of 5-10 drugs with low molecular weight, which is cheaper, like aspirin)

The iTind™, a temporarily implanted nitinol device, is placed in the prostatic urethra in a folded configuration. The super-elastic nitinol struts exert ischemic pressure at the 12, 5, and 7 o’clock positions, reshaping the tissue to allow urine to flow. After 5 to 7 days, the device is completely removed, and patients experience immediate relief.